![Dmitry Soloviev](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dmitry Soloviev is the founder of Cambridge Oncometrix Ltd.
He held the title of Principal Scientist, but is no longer active in that role.
He also held the positions of Founder (FOU) and Chief Technology Officer (CTO) at the company.
Aktive Positionen von Dmitry Soloviev
Unternehmen | Position | Beginn |
---|---|---|
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | Health Technology |